eConsent Implementation – A Necessary Innovation and Optimisation in the Protea Paediatric Trial
Introduction The Protea study, an innovative paediatric trial focusing on prematurely born children in the Netherlands, has introduced eConsent to
Your Research is now part of the Almac Group. Read more here about this strategic acquisition.
Introduction The Protea study, an innovative paediatric trial focusing on prematurely born children in the Netherlands, has introduced eConsent to